AUROPHARMA.NS vs. SUNPHARMA.NS
Compare and contrast key facts about Aurobindo Pharma Limited (AUROPHARMA.NS) and Sun Pharmaceutical Industries Limited (SUNPHARMA.NS).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AUROPHARMA.NS or SUNPHARMA.NS.
Key characteristics
| AUROPHARMA.NS | SUNPHARMA.NS | |
|---|---|---|
| YTD Return | 6.88% | 21.97% |
| 1Y Return | 81.61% | 63.83% |
| 3Y Return (Ann) | 5.66% | 32.20% |
| 5Y Return (Ann) | 12.62% | 32.31% |
| 10Y Return (Ann) | 14.99% | 10.57% |
| Sharpe Ratio | 2.99 | 3.34 |
| Daily Std Dev | 29.62% | 18.19% |
| Max Drawdown | -86.50% | -71.46% |
| Current Drawdown | -1.95% | -6.25% |
Fundamentals
| AUROPHARMA.NS | SUNPHARMA.NS | |
|---|---|---|
| Market Cap | ₹662.23B | ₹3.63T |
| EPS | ₹47.24 | ₹37.06 |
| PE Ratio | 23.92 | 40.88 |
| Revenue (TTM) | ₹278.95B | ₹474.45B |
| Gross Profit (TTM) | ₹135.62B | ₹332.24B |
| EBITDA (TTM) | ₹48.94B | ₹128.15B |
Correlation
The correlation between AUROPHARMA.NS and SUNPHARMA.NS is 0.42, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
AUROPHARMA.NS vs. SUNPHARMA.NS - Performance Comparison
In the year-to-date period, AUROPHARMA.NS achieves a 6.88% return, which is significantly lower than SUNPHARMA.NS's 21.97% return. Over the past 10 years, AUROPHARMA.NS has outperformed SUNPHARMA.NS with an annualized return of 14.99%, while SUNPHARMA.NS has yielded a comparatively lower 10.57% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
AUROPHARMA.NS vs. SUNPHARMA.NS - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Aurobindo Pharma Limited (AUROPHARMA.NS) and Sun Pharmaceutical Industries Limited (SUNPHARMA.NS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
AUROPHARMA.NS vs. SUNPHARMA.NS - Dividend Comparison
AUROPHARMA.NS's dividend yield for the trailing twelve months is around 0.39%, less than SUNPHARMA.NS's 0.82% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AUROPHARMA.NS Aurobindo Pharma Limited | 0.39% | 0.55% | 1.37% | 0.61% | 0.46% | 0.55% | 0.31% | 0.40% | 0.40% | 0.30% | 0.29% | 0.70% |
SUNPHARMA.NS Sun Pharmaceutical Industries Limited | 0.82% | 0.91% | 1.00% | 0.89% | 0.68% | 0.64% | 0.46% | 0.61% | 0.16% | 0.37% | 0.18% | 0.44% |
Drawdowns
AUROPHARMA.NS vs. SUNPHARMA.NS - Drawdown Comparison
The maximum AUROPHARMA.NS drawdown since its inception was -86.50%, which is greater than SUNPHARMA.NS's maximum drawdown of -71.46%. Use the drawdown chart below to compare losses from any high point for AUROPHARMA.NS and SUNPHARMA.NS. For additional features, visit the drawdowns tool.
Volatility
AUROPHARMA.NS vs. SUNPHARMA.NS - Volatility Comparison
Aurobindo Pharma Limited (AUROPHARMA.NS) has a higher volatility of 8.55% compared to Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) at 6.31%. This indicates that AUROPHARMA.NS's price experiences larger fluctuations and is considered to be riskier than SUNPHARMA.NS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
AUROPHARMA.NS vs. SUNPHARMA.NS - Financials Comparison
This section allows you to compare key financial metrics between Aurobindo Pharma Limited and Sun Pharmaceutical Industries Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities